• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Insufficient Information (3190)
Patient Problems Abdominal Pain (1685); Autoimmune Disorder (1732); Emotional Changes (1831); Fatigue (1849); Hair Loss (1877); Memory Loss/Impairment (1958); Pain (1994); Rash (2033); Skin Irritation (2076); Swelling (2091); Anxiety (2328); Arthralgia (2355); Malaise (2359); Depression (2361); Confusion/ Disorientation (2553); Heavier Menses (2666)
Event Date 01/01/2017
Event Type  Injury  
Event Description
This case was initially received via regulatory authority (fda, reference number: mw5081415) on 30-nov-2018.This spontaneous case was reported by a consumer and describes the occurrence of menorrhagia ("heavy period"), amnesia ("memory loss") and autoimmune disorder ("potential autoimmune disorder") in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On (b)(6) 2013, the patient had essure inserted.In 2013, the patient experienced amnesia (seriousness criterion disability), paranoia ("paranoia"), anxiety ("anxiety"), disturbance in attention ("concentration /focus issue") and mood swings ("mood swings").In 2017, the patient experienced menorrhagia (seriousness criteria medically significant and intervention required), dysmenorrhoea ("painful period"), abdominal pain upper ("painful stomach"), arthralgia ("joint pain") and somnolence ("sometimes needing 12-18 hours of sleep per day").On an unknown date, the patient experienced autoimmune disorder (seriousness criterion medically significant), depression ("depression"), feeling abnormal ("brain fog"), vitamin d deficiency ("very low vitamin d"), fatigue ("constant fatigue"), alopecia ("hair loss"), rash macular ("dry red patches"), dry skin ("dry skin"), skin atrophy ("thin skin"), skin disorder ("wrinkled skin"), malaise ("malaise"), tooth disorder ("multiple teeth having degradation") and swelling ("swelling during ovulation") and was found to have white blood cell count increased ("higher white blood cell count ").The patient was treated with surgery (essure removal).Essure was removed on (b)(6) 2018.At the time of the report, the menorrhagia, amnesia, autoimmune disorder, paranoia, anxiety, depression, feeling abnormal, disturbance in attention, mood swings, vitamin d deficiency, fatigue, alopecia, rash macular, dry skin, skin atrophy, skin disorder, malaise, white blood cell count increased, tooth disorder, dysmenorrhoea, abdominal pain upper, swelling, arthralgia and somnolence outcome was unknown.The reporter provided no causality assessment for abdominal pain upper, alopecia, amnesia, anxiety, arthralgia, autoimmune disorder, depression, disturbance in attention, dry skin, dysmenorrhoea, fatigue, feeling abnormal, malaise, menorrhagia, mood swings, paranoia, rash macular, skin atrophy, skin disorder, somnolence, swelling, tooth disorder, vitamin d deficiency and white blood cell count increased with essure.Incident no lot number or device sample was received in this case.At this time, we have no information suggesting that the device failed to meet its specifications.We will conduct a review of our complaint records and other non-conformances data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981
MDR Report Key8176038
MDR Text Key130778906
Report Number2951250-2018-05143
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial
Report Date 12/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Initial Date Manufacturer Received 11/30/2018
Initial Date FDA Received12/18/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-